Acorn Financial Advisory Services Inc Abb Vie Inc. Transaction History

Acorn Financial Advisory Services Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$133.59 - $154.65 $10,553 - $12,217	-79 Reduced 3.28%	2,332 $347,000
Q2 2023 Jul 20, 2023	BUY	$132.51 - $164.9 $25,044 - $31,166	189 Added 8.51%	2,411 $324,000
Q1 2023 Apr 26, 2023	BUY	$144.61 - $166.54 $321,323 - $370,051	2,222 New	2,222 $354,000

4,095

1.28B

16.7M

15M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $357B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Acorn Financial Advisory Services Inc , based on Form 13F filings with the SEC.

Stay updated on Acorn Financial Advisory Services Inc with notifications on news.